Abstract
The iodine-specific detection techniques X-ray fluorescence spectrometry, neutron activation analysis and radiochemical detection of 125I-labelled substance are well suited for quantification of iodixanol in biological samples. The limit of detection is 60 μg iodixanol/ml for X-ray fluorescence analysis and 1 to 10 μg iodixanol/ml for neutron activation analysis. Reversed-phase high-performance liquid chromatography (HPLC) has been employed when selective determination of iodixanol was needed for identificational purposes or when quantification of very small amounts of iodixanol was essential. An optimized HPLC method for quantification of iodixanol in rat serum and urine is presented. The limit of detection for this method is 0.20 μg iodixanol/ml for rat serum and 3.0 μg iodixanol/ml for rat urine.
When samples were analyzed by HPLC and thin layer chromatography, no metabolites of iodixanol were observed in rat, monkey or human urine, or in rat kidney and bile. Studies with equilibrium dialysis and HPLC determination of iodixanol showed no protein binding of the contrast agent in human plasma; the 95% confidence interval for the result was 0.0±2.1%.
Keywords
Get full access to this article
View all access options for this article.